SCIENTIFIC DIRECTORS
Lorenzo Belluomini – Verona
Sara Pilotto – Verona
FACULTY
Fabrice Barlesi – Paris
Alessandra Bearz – Aviano (PN)
Lorenzo Belluomini – Verona
Laura Bonanno – Padua
Diego Cortinovis – Monza (MB)
Valeria Dionisi – Verona
Niccolo’ Giaj Levra – Negrar of Valpolicella (VR)
Carlo Genova – Genoa
Salvatore Grisanti – Brescia
Maurizio Valentino Carlo Luigi Infante – Verona
Alessandro Inno – Negrar of Valpolicella (VR)
Alessandro Leonetti – Parma
Marianna Macerelli – Udine
Jessica Menis – Verona
FACULTY
Michele Milella – Verona
Silvia Novello – Turin
Giulia Pasello – Padua
Francesco Passiglia – Turin
Alberto Pavan – Venice Mestre (VE)
Giacomo Pelizzari – Udine
Sara Pilotto – Verona
Elisa Roca – Peschiera Del Garda (VR)
Giovanni Rossi – Genoa
Marco Schiavon – Padua
Matteo Sepulcri – Padua
Marco Sposito – Peschiera Del Garda (VR)
Marcello Tiseo – Parma
Lung cancer remains a leading cause of cancer-related mortality worldwide, with non-small cell lung cancer (NSCLC) accounting for the majority of cases. Advances in molecular biology, early detection, and targeted therapies are reshaping treatment paradigms, offering new hope for patients. Despite these innovations, challenges remain in optimizing treatment strategies, overcoming resistance mechanisms, and improving long-term outcomes.
Key areas of focus include adjuvant and neoadjuvant strategies, perioperative approaches, resectability considerations, and cutting-edge treatments for advanced and metastatic disease. Experts will also explore the evolving role of precision medicine and prevention in lung cancer care.
Through lectures, clinical case discussions, and interactive sessions, this event aims to foster interdisciplinary collaboration and drive innovation in NSCLC treatment. Join us in Verona to shape the future of lung cancer care.
|
1:00 p.m. – 2.00 p.m. |
Registration |
|
2:00 p.m. – 2.30 p.m. |
Opening Remarks: welcome, introduction, and educational objectives of the course – L. Belluomini, S. Pilotto |
|
SESSION 1: CRACKING THE CODE OF ADJUVANT AND NEOADJUVANT TREATMENTS |
|
|
2:30 p.m. – 3:00 p.m. |
Lecture 1: Adjuvant Strategies in NSCLC With Molecular Alterations: Opportunities and Challenges – F. Passiglia |
|
3:00 p.m. – 3:20 p.m. |
Clinical Case 1: Adjuvant Treatment with Molecular Alterations – M. Sposito |
|
3:20 p.m. – 3:35 p.m. |
Open Discussion of previoulsy covered topics – M. Sposito, F. Passiglia |
|
3:35 p.m. – 3:50 p.m. |
Coffee Break |
|
|
Moderators: A. Bearz, L. Bonanno, M. V. C. L. Infante |
|
3:50 p.m. – 4:20 p.m. |
Lecture 2: Perioperative Approaches in NSCLC: Expanding Horizons – M. Tiseo |
|
4:20 p.m. – 4:40 p.m. |
Clinical Case 2: Perioperative Treatment in Practice – G. Pelizzari |
|
4:40 p.m. – 4:55 p.m. |
Open Discussion of previoulsy covered topics – G. Pelizzari, M. Tiseo |
|
4:55 p.m. – 5:25 p.m. |
Lecture 3: Resectability for Dummies – M. Schiavon |
|
5:25 p.m. – 5:40 p.m. |
Open Discussion of previoulsy covered topics – M. Schiavon |
|
SESSION 2: VISIONARY INSIGHTS |
|
|
5:40 p.m. – 6:10 p.m. |
Lectio Magistralis: Primary/secondary prevention – S. Novello |
|
6:10 p.m. – 6:45 p.m. |
Open Discussion of previoulsy covered topics – S. Novello |
|
6:45 p.m. – 7:15 p.m. |
Closing Remarks – L. Belluomini, S. Pilotto |
|
8:45 a.m. – 9:00 a.m. |
Opening of the second day of the scientific program – L. Belluomini, S. Pilotto |
|
|
SESSION 1: GAME-CHANGING PERSPECTIVES |
|
9:00 a.m. – 9:30 a.m. |
Lectio Magistralis: Pioneering Treatments in Advanced and Metastatic NSCLC – F. Barlesi |
|
|
SESSION 2: PUSHING THE BOUNDARIES IN ADVANCED DISEASE |
|
9:30 a.m. – 10:00 a.m. |
Lecture 1: Locally Advanced Unresectable NSCLC: Challenges and Advances – C. Genova |
|
10:00 a.m. – 10:20 a.m. |
Clinical Case 1: Management of Locally Advanced Unresectable NSCLC – G. Rossi |
|
10:20 a.m. – 10:35 a.m. |
Open Discussion of previoulsy covered topics – C. Genova, G. Rossi |
|
10:35 a.m. – 11:05 a.m. |
Lecture 2: Irradiability for Dummies – N. Giaj Levra |
|
11:05 a.m. – 11:20 a.m. |
Open Discussion of previoulsy covered topics – N. Giaj Levra |
|
11:20 a.m. – 11:35 a.m. |
Coffee Break |
|
Moderators: A. Inno, E. Roca |
|
|
11:35 a.m. – 12:05 a.m. |
Lecture 3: NSCLC Without Molecular Alterations: State-of-the-Art and Updates – D. Cortinovis |
|
12:05 a.m. – 12:25 a.m. |
Clinical Case 2: PD to First-Line Therapy in NSCLC Without Molecular Alterations – A. Pavan |
|
12:25 a.m. – 12:40 a.m. |
Open Discussion of previoulsy covered topics – D. Cortinovis, A. Pavan |
|
|
Moderators: S. Grisanti, M. Macerelli, J. Menis |
|
12:40 a.m. – 1:10 p.m. |
Lecture 4: First-Line Treatment of EGFR-Mutated NSCLC: an evolving landscape – G. Pasello |
|
1:10 p.m. – 1:30 p.m. |
Clinical Case 3: EGFR-Mutated NSCLC in First-Line Settings – A. Leonetti |
|
1:30 p.m. – 1:45 p.m. |
Open Discussion of previoulsy covered topics – A. Leonetti, G. Pasello |
|
1.45 p.m. – 2:00 p.m. |
Closing Remarks and Adjournment – L. Belluomini, S. Pilotto |
